| R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth.
Authors: Fulciniti M, Amodio N, Bandi R, Cagnetta A, Samur M, Acharya C, Prabhala R, DAquila P, Bellizzi D, Passarino G, Adamia S, Neri A, Hunter Z, Treon S, Anderson K, Tassone P, Munshi N
Blood Cancer J, 2016;6(0):e380.
Species: Human
Sample Type: Whole Cells
Combination drug scheduling defines a "window of opportunity" for chemopotentiation of gemcitabine by an orally bioavailable, selective ChK1 inhibitor, GNE-900.
Authors: Blackwood E, Epler J, Yen I, Flagella M, OBrien T, Evangelista M, Schmidt S, Xiao Y, Choi J, Kowanetz K, Ramiscal J, Wong K, Jakubiak D, Yee S, Cain G, Gazzard L, Williams K, Halladay J, Jackson P, Malek S
Mol Cancer Ther, 2013;12(10):1968-80.
Species: Human
Sample Type: Whole Cells
Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models.
Authors: Zibara K, Hamdan R, Dib L
PLoS ONE, 2012;7(7):e40140.
Species: Human
Sample Type: Whole Cells
Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
Authors: Doepfner KT, Spertini O, Arcaro A
Leukemia, 2007;21(9):1921-30.
Species: Human
Sample Type: Whole Cells
|
